Clinical guidelines universally recommend statin therapy for patients with diabetes based on established risk and age brackets to prevent cardiovascular events. Multiple studies and major society standards consistently support these recommendations.
The claim is specific, empirical, and contestable (or rather, verifiable through clinical guidelines and empirical literature). The retrieved literature uniformly points to the fact that major health organizations (such as the ADA, ACC, and AHA) issue clinical guidelines recommending statins for diabetic patients based on age and cardiovascular risk stratification, and that these therapies yield positive outcomes. Consequently, the balance verdict is SUPPORTED with zero refuting papers.